Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

HemoShear announces name change
August 2015
by  |  Email the author
EDIT CONNECT

SHARING OPTIONS:

CHARLOTTESVILLE, Va.—HemoShear has announced that it will be changing its name to HemoShear Therapeutics to reflect its new concentration on drug discovery, with its initial focus on developing therapies for nonalcoholic steatohepatitis (NASH) and organic acidemias, a group of rare genetic metabolic disorders. The company will be leveraging REVEAL-Tx, its proprietary platform, which offers the ability to characterize metabolic disorders by revealing complex human pathophysiological pathways.
 
“In late 2014, we established a collaboration with Children’s National Medical Center to discover drugs for children with rare metabolic diseases,” Vincent Aurentz, president of HemoShear Therapeutics, commented in a statement. “HemoShear Therapeutics is focusing on a family of rare disorders responsible for chemical imbalances in the body that result in life-threatening health complications at an early age. Tragically, these young patients rarely live past their teens and no drugs exist to treat their diseases.”
 
Code:

Back



PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2017 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.